As generally accepted for immune cells and other types of cancer cells [26–28], IFN-γ activated the STAT1-IRF1 pathway, and thereby upregulated PD-L1 expression in MM cells (Figure 1A and 1B). The gene discussed is IRF1; the disease is cancer.